The role of integrins in tumor angiogenesis

Hematology/Oncology Clinics of North America

Volumn 18, Issue 5, 2004, Pages 991-1006

  Hwang, Rosa ^a   Varner, Judy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATN 161; BETA1 INTEGRIN; CD51 ANTIGEN; CELL ADHESION MOLECULE; CILENGITIDE; INTEGRIN; INTEGRIN ANTAGONIST; LAMININ; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 17E6; MONOCLONAL ANTIBODY LM 609; PROTEIN INHIBITOR; S 247; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANGIOGENESIS; CANCER THERAPY; CELLULAR DISTRIBUTION; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE MARKER; DRUG TARGETING; EOSINOPHIL; FEVER; HUMAN; LYMPHOCYTE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTEGRINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 5044234212     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.09.010     Document Type: Review

References (78)

1. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat Rev Cancer 2 2002 727 739
2. J. Folkman Angiogenesis-dependent diseases Semin Oncol 28 2001 536 542
3. K.M. Hodivala-Dilke, A.R. Reynolds, and L.E. Reynolds Integrins in angiogenesis: multitalented molecules in a balancing act Cell Tissue Res 314 2003 131 144
4. F.G. Giancotti, and E. Ruoslahti Integrin signaling Science 285 1999 1028 1032
5. E.F. Plow, T.A. Haas, L. Zhang, J. Loftus, and J.W. Smith Ligand binding to integrins J Biol Chem 275 2000 21785 21788
6. A. van der Flier, and A. Sonnenberg Function and interactions of integrins Cell Tissue Res 305 2001 285 298
7. K. Burridge, and M. Chrzanowska-Wodnicka Focal adhesions, contractility and signaling Annu Rev Cell Dev Biol 12 1996 463 518
8. P.C. Brooks, R.A. Clark, and D. Cheresh Requirement of vascular integrin αvβ3 for angiogenesis Science 264 1994 569 571
9. T. Carlson, Y. Feng, P. Maisonpierre, M. Mrksich, and A.O. Morla Direct cell adhesion to the angiopoietins mediated by integrins J Biol Chem 276 2001 26516 26525
10. S. Kim, K. Bell, S.A. Mousa, and J.A. Varner Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin Am J Pathol 156 2000 1345 1362
11. P.C. Brooks, S. Silletti, T.L. von Schalscha, M. Friedlander, and D.A. Cheresh Disruption of angiogenesis by PEX. a noncatalytic metalloproteinase fragment with integrin binding activity Cell 92 1998 391 400
12. P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, and W.G. Stetler-Stevenson Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3 Cell 85 1996 683 693
13. B. Eliceiri, and D. Cheresh The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development J Clin Invest 103 9 1999 1227 1230
14. B. Eliceiri, R. Paul, R.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability Mol Cell 4 1999 915 924
15. N. Boudreau, and J.A. Varner The homeobox transcription factor Hox D3 promotes integrin α5β1 expression and function during angiogenesis J Biol Chem 279 2003 4862 4868
16. J. Zhong, B. Eliceiri, D. Stupack, K. Penta, G. Sakamoto, and T. Quertermous Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1 J Clin Invest 112 1 2003 30 41
17. S. Stromblad, J.C. Becker, M. Yebra, P.C. Brooks, and D.A. Cheresh Suppression of p53 Activity and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis J Clin Invest 98 2 1996 426 433
18. D.G. Stupack, X.S. Puente, S. Boutsaboualoy, C.M. Storgard, and D.A. Cheresh Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins J Cell Biol 155 3 2001 459 470
19. M. Bakre, Y. Zhu, H. Yin, D.W. Burton, R. Terkeltaub, and L.J. Deftos Parathyroid hormone-related peptide is a naturally occurring, protein kinase A-dependent angiogenesis inhibitor Nat Med 8 9 2002 995 1003
20. J. Meredith, B. Fazeli, and M. Schwartz The extracellular matrix as a cell survival factor Mol Biol Cell 4 9 1993 953 961
21. S. Kim, M. Bakre, H. Yin, and J.A. Varner Inhibition of endothelial cell survival and angiogenesis by protein kinase A J Clin Invest 110 7 2002 933 941
22. Z. Zhang, K. Vuori, J. Reed, and E. Ruoslahti The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression Proc Natl Acad Sci USA 92 13 1995 6161 6165
23. A. Pozzi, K.K. Wary, F.G. Giancotti, and H.A. Gardner Integrin alpha 1beta 1 mediates a unique collagen-dependent proliferation pathway in vivo J Cell Biol 142 2 1998 587 594
24. J. Yang, H. Rayburn, and R.O. Hynes Embryonic mesodermal defects in alpha(5) integrin-deficient mice Development 119 1993 1093 1105
25. S. Kim, M. Harris, and J.A. Varner Regulation of integrin alpha v beta 3-mediated endothelial cell migration and angiogenesis by integrin alpha 5 beta 1 and protein kinase A J Biol Chem 275 43 2000 33920 33928
26. J. Enenstein, N.S. Waleh, and R.H. Kram Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells Exp Cell Res 203 1992 499 503
27. P.C. Brooks Integrin alphav beta3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Cell 79 1994 1157 1164
28. J. Enenstein, and R.H. Kramer Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin J Invest Dermatol 103 1994 381 386
29. B. Felding-Habermann, B. Mueller, C. Romerdahl, and D.A. Cheresh Involvement of integrin αv gene expression in human melanoma tumorigenicity J Clin Invest 89 1992 2018 2022
30. B. Bader, H. Rayburn, D. Crowley, and R.O. Hynes Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins Cell 95 1998 507 519
31. K.M. Hodivala-Dilke, K.P. McHugh, D.A. Tsakiris, H. Rayburn, D. Crowley, and M. Ullman-Cullere β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival J Clin Invest 103 2 1999 229 238
32. S. Miyamoto, H. Teramoto, J. Gutkind, and K.M. Yamada Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors J Cell Biol 135 1996 1633 1642
33. B. Eliceiri, and D. Cheresh Adhesion events in angiogenesis Curr Opin Chem Biol 13 2001 563 568
34. B. Eliceiri, R. Klemke, S. Stromblad, and D.A. Cheresh Integrin alphav beta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis J Cell Biol 140 5 1998 1255 1263
35. P.C. Brooks, S. Stromblad, R. Klemke, D. Visscher, F.H. Sarkar, and D.A. Cheresh Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin J Clin Invest 96 4 1995 1815 1822
36. M. Friedlander, P. Brooks, R. Shaffer, C.M. Kincaid, J.A. Varner, and D.A. Cheresh Definition of two angiogenic pathways by distinct αv integrins Science 270 1995 1500 1502
37. L. Reynolds, L. Wyder, J. Lively, D. Taverna, S.D. Robinson, and X. Huang Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins Nat Med 8 1 2002 27 34
38. D. Cheresh, and D. Stupack Integrin-mediated death: an explanation of the integrin-knockout phenotype? Nat Med 8 3 2002 193 194
39. Y. Maeshima, M. Manfredi, C. Reimer, K.A. Holthaus, H. Hopfer, and B.R. Chandamuri Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin J Biol Chem 276 18 2001 15240 15248
40. R. Fassler, M. Pfaff, J. Murphy, A.A. Noegel, S. Johansson, and R. Timpl Lack of β1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts J Cell Biol 128 1995 979 988
41. L. Stephens, A. Sutherland, I. Klimanskaya, A. Andrieux, J. Meneses, and R.A. Pedersen Deletion of beta-1 integrins in mice results in inner cell mass failure and periimplantation lethality Genes Dev 9 1995 1883 1895
42. W. Bloch, E. Forsberg, S. Lentini, C. Brakebusch, K. Martin, and H.W. Krell Beta1 integrin is essential for teratoma growth and angiogenesis J Cell Biol 139 1997 265 278
43. D. Senger, K. Claffey, J. Benes, C.A. Perruzzi, A.P. Sergiou, and M. Detmar Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1 beta1 and alpha2 beta1 integrins Proc Natl Acad Sci U S A 94 25 1997 13612 13617
44. D.R. Senger, C. Perruzzi, M. Streit, V.E. Koteliansky, A.R. de Fougerolles, and M. Detmar The alpha(1) beta(1) and alpha(2) beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis Am J Pathol 160 1 2002 195 204
45. J. Chen, T. Diacovo, D. Grenache, S.A. Santoro, and M.M. Zutter The alpha(2) integrin subunit-deficient mouse-a multifaceted phenotype including defects of branching morphogenesis and hemostasis Am J Pathol 161 2002 337 344
46. H.A. Gardner, J. Kreidberg, V. Koteliansky, and R. Jaenisch Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion Dev Biol 175 1996 301 313
47. J. Kriedberg, M. Donovan, S. Goldstein, H. Rennke, K. Shepherd, and R.C. Jones Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis Development 122 1996 3537 3547
48. E. GeorgesLabouesse, N. Messaddeq, G. Yehia, L. Cadalbert, A. Dierich, and M. Le Meur Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice Nat Genet 13 1996 370 373
49. C. DiPersio, R. van der Neut, E. GeorgesLabouesse, J.A. Kreidberg, A. Sonnenberg, and R.O. Hynes alpha3 beta1 and alpha6 beta4 integrin receptors for laminin-5 are not essential for epidermal morphogenesis and homeostasis during skin development J Cell Sci 113 2000 3051 3062
50. C. DiPersio, K.M. Hodivala-Dilke, R. Jaenisch, J.A. Kreidberg, and R.O. Hynes α3β1 integrin is required for normal development of the epidermal basement membrane J Cell Biol 137 1997 729 742
51. E. Shin, J. Lee, M. Park, Y.H. Chin, G.B. Jeong, and S.Y. Kim Overexpressed alpha(3) beta(1) and constitutively activated extracellular signal-regulated kinase modulate the angiogenic properties of ECV304 cells Mol Cells 9 1999 138 145
52. S. Hughes Functional characterization of the spontaneously transformed human umbilical vein endothelial cell lines ECV304: use in an in vitro model of angiogenesis Exp Cell Res 225 1996 171 185
53. J.C. Gutheil, T.N. Campbell, P.R. Pierce, J.D. Watkins, W.D. Huse, and D.J. Bodkin Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3 Clin Cancer Res 6 2000 3056 3061
54. S.R. Patel, J. Jenkins, N. Papadopolous, M.A. Burgess, C. Plager, and J. Gutterman Pilot study of vitaxin-an angiogenesis inhibitor-in patients with advanced leiomyosarcomas Cancer 92 5 2001 1347 1348
55. J. Posey, M. Khazaeli, A. DelGrosso, M.N. Saleh, C.Y. Lin, and W. Huse A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer Cancer Biother Radiopharm 16 2 2001 125 132
56. B.K. Ward, J.H. Heinrichs, and M. Mancini Inhibition of growth of human melanoma xenografts by Vitaxin, a humanized monoclonal antibody specific for alphav beta3 Proc Am Assoc Cancer Res 2003
57. J. Pizzolato, S. Sharma, and R. Maki Phase I study of Medi-522, an alpha v beta 3 integrin inhibitor, in patients with irinotecan-refractory colorectal cancer (CRC) Proc Am Soc Clin Oncol 2003
58. F. Mitjans, T. Meyer, C. Fittschen, S. Goodman, A. Jonczyk, and J.F. Marshall In vivo therapy of malignant melanoma by means of antagonists of αv integrins Int J Cancer 87 2000 716 723
59. N. Reinmuth, W. Liu, S.A. Ahmad, F. Fan, O. Stoeltzing, and A.A. Parikh αvβ3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice Cancer Res 63 2003 2079 2087
60. F. Eskens, H. Dumez, R. Hoekstra, A. Perschl, C. Brindley, and S. Bottcher Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours Eur J Cancer 39 2003 917 926
61. P. Burke, S. DeNardo, L. Miers, K.R. Lamborn, S. Matzku, and G.L. DeNardo Cilengitide targeting of alpha(v) beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts Cancer Res 62 15 2002 4263 4272
62. T. MacDonald, T. Taga, H. Shimada, P. Tabrizi, B.V. Zlokovic, and D.A. Cheresh Preferential susceptibility of brain tumors to the antiangiogenic effects of an αv integrin antagonist Neurosurgery 48 2001 151 157
63. O. Stoeltzing, W. Liu, N. Reinmuth, F. Fan, G.C. Parry, and A.A. Parikh Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice Int J Cancer 104 2003 496 503
64. S. Kim, K. Bell, S.A. Mousa, and J.A. Varner Regulation of angiogenesis in vivo by ligation of integrin {alpha}5{beta}1 with the central cell-binding domain of fibronectin Am J Pathol 156 4 2000 1345 1362
65. A. Pfeifer, T. Kessler, S. Silletti, D.A. Cheresh, and I.M. Verma Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2 Proc Natl Acad Sci USA 97 22 2000 12227 12232
66. G. Gasparini, P.C. Brooks, E. Biganzoli, P.B. Vermeulen, E. Bonoldi, and L.Y. Dirix Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer Clin Cancer Res 4 11 1998 2625 2634
67. A. Vonlaufen, G. Wiedle, B. Borisch, S. Birrer, P. Luder, and B.A. Imhof Integrin alpha (v) beta(3) expression in colon carcinoma correlates with survival Mod Pathol 14 11 2001 1126 1132
68. H. Sawai, H. Funahashi, Y. Matsuo, M. Yamamoto, Y. Okada, and T. Hayakawa Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas Dig Dis Sci 48 7 2003 1241 1250
69. H. Sawai, M. Yamamoto, Y. Okada, M. Sato, Y. Akamo, and H. Takeyama Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells Pancreas 23 4 2001 399 405
70. J.D. Hood, M. Bednarski, R. Frausto, S. Guccione, R.A. Reisfeld, and R. Xiang Tumor regression by targeted gene delivery to the neovasculature Science 296 2002 2404 2407
71. E. Koivunen, B. Wang, and E. Ruoslahti Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins Biotechnology (N Y) 13 3 1995 265 270
72. R. Pasqualini, E. Koivunen, and E. Ruoslahti Alpha v integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15 6 1997 542 546
73. E. Ruoslahti RGD and other recognition sequences for integrins Annu Rev Cell Dev Biol 12 1996 697 715
74. W. Arap, R. Pasqualini, and E. Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 5349 1998 377 380
75. W. Arap, M. Kolonin, M. Trepel, J. Lahdenranta, M. Cardo-Vila, and R.J. Giordano Steps toward mapping the human vasculature by phage display Nat Med 8 2 2002 121 127
76. P. Mintz, J. Kim, K. Do, X. Wang, R.G. Zinner, and M. Cristofanilli Fingerprinting the circulating repertoire of antibodies from cancer patients Nat Biotechnol 21 1 2003 37 38
77. D. Sipkins, D. Cheresh, M. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C. Li Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging Nat Med 4 5 1998 623 626
78. 18F-labeled RGD-containing glycopeptide and positron emission tomography Cancer Res 61 2001 1781 1785